A. Joy, C. Beaudry, N. Tran, F. Ponce, and D. Holz, Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis, Journal of Cell Science, vol.116, issue.21, 2003.
DOI : 10.1242/jcs.00712

L. Mariani, C. Beaudry, W. Mcdonough, D. Hoelzinger, and T. Demuth, Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis, Journal of Neuro-Oncology, vol.53, issue.2, pp.161-176, 2001.
DOI : 10.1023/A:1012253317934

N. De-la-iglesia, G. Konopka, K. Lim, C. Nutt, and J. Bromberg, Deregulation of a STAT3-Interleukin 8 Signaling Pathway Promotes Human Glioblastoma Cell Proliferation and Invasiveness, Journal of Neuroscience, vol.28, issue.23, pp.5870-587810, 2008.
DOI : 10.1523/JNEUROSCI.5385-07.2008

M. Ehtesham, J. Winston, P. Kabos, and R. Thompson, CXCR4 expression mediates glioma cell invasiveness, Oncogene, vol.277, issue.19, pp.2801-2806, 2006.
DOI : 10.1038/sj.onc.1209302

K. Wakabayashi, F. Kambe, X. Cao, R. Murakami, and H. Mitsuyama, Inhibitory effects of cyclosporin A on calcium mobilization-dependent interleukin-8 expression and invasive potential of human glioblastoma U251MG cells, Oncogene, vol.23, issue.41, pp.6924-6932, 2004.
DOI : 10.1038/sj.onc.1207778

M. Chicoine and D. Silbergeld, Mitogens as motogens, Journal of Neuro-Oncology, vol.35, issue.3, pp.249-257, 1997.
DOI : 10.1023/A:1005808315821

J. Rubin, A. Kung, R. Klein, J. Chan, and Y. Sun, A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors, Proceedings of the National Academy of Sciences, vol.100, issue.23, pp.13513-13518, 2003.
DOI : 10.1073/pnas.2235846100

A. Bajetto, F. Barbieri, A. Dorcaratto, S. Barbero, and A. Daga, Expression of CXC chemokine receptors 1???5 and their ligands in human glioma tissues: Role of CXCR4 and SDF1 in glioma cell proliferation and migration, Neurochemistry International, vol.49, issue.5, pp.423-432, 2006.
DOI : 10.1016/j.neuint.2006.03.003

D. Zagzag, M. Esencay, O. Mendez, H. Yee, and I. Smirnova, Hypoxia- and Vascular Endothelial Growth Factor-Induced Stromal Cell-Derived Factor-1??/CXCR4 Expression in Glioblastomas, The American Journal of Pathology, vol.173, issue.2, pp.545-560, 2008.
DOI : 10.2353/ajpath.2008.071197

S. Rempel, S. Dudas, S. Ge, and J. Gutiérrez, Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma, Clin Cancer Res, vol.6, pp.102-111, 2000.

Y. Rong, D. Durden, V. Meir, E. Brat, and D. , ???Pseudopalisading??? Necrosis in Glioblastoma: A Familiar Morphologic Feature That Links Vascular Pathology, Hypoxia, and Angiogenesis, Journal of Neuropathology & Experimental Neurology, vol.65, issue.6, pp.529-539, 2006.
DOI : 10.1097/00005072-200606000-00001

D. Zagzag, Y. Lukyanov, L. Lan, M. Ali, and M. Esencay, Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion, Laboratory Investigation, vol.4, issue.12, pp.1221-1232, 2006.
DOI : 10.1038/nm1075

J. Stommel, A. Kimmelman, H. Ying, R. Nabioullin, and A. Ponugoti, Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies, Science, vol.318, issue.5848, p.17872411, 2007.
DOI : 10.1126/science.1142946

A. Ekstrand, C. James, W. Cavenee, B. Seliger, and R. Pettersson, Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo, Cancer Res, vol.51, pp.2164-2172, 1991.

A. Aguirre, T. Rizvi, N. Ratner, and V. Gallo, Overexpression of the Epidermal Growth Factor Receptor Confers Migratory Properties to Nonmigratory Postnatal Neural Progenitors, Journal of Neuroscience, vol.25, issue.48, pp.11092-11106, 2005.
DOI : 10.1523/JNEUROSCI.2981-05.2005

B. Woerner, N. Warrington, A. Kung, A. Perry, and J. Rubin, Widespread CXCR4 Activation in Astrocytomas Revealed by Phospho-CXCR4-Specific Antibodies, Cancer Research, vol.65, issue.24, pp.11392-11399, 2005.
DOI : 10.1158/0008-5472.CAN-05-0847

I. Nazarenko, S. Hede, X. He, A. Hedrén, and J. Thompson, PDGF and PDGF receptors in glioma, Upsala Journal of Medical Sciences, vol.6, issue.2, p.22509804, 2012.
DOI : 10.1523/JNEUROSCI.3970-05.2006

C. Brennan, H. Momota, D. Hambardzumyan, T. Ozawa, and A. Tandon, Glioblastoma Subclasses Can Be Defined by Activity among Signal Transduction Pathways and Associated Genomic Alterations, PLoS ONE, vol.5, issue.11, 2009.
DOI : 10.1371/journal.pone.0007752.s010

D. Hägerstrand, G. Hesselager, S. Achterberg, W. Bolin, U. Kowanetz et al., Characterization of an imatinib-sensitive subset of high-grade human glioma cultures, Oncogene, vol.23, issue.35, pp.4913-4922, 2006.
DOI : 10.1038/sj.onc.1209497

N. Delcourt, J. Bockaert, and P. Marin, GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation, Trends in Pharmacological Sciences, vol.28, issue.12, pp.602-607, 2007.
DOI : 10.1016/j.tips.2007.09.007

B. Shah and K. Catt, GPCR-mediated transactivation of RTKs in the CNS: mechanisms and consequences, Trends in Neurosciences, vol.27, issue.1, pp.48-53, 2004.
DOI : 10.1016/j.tins.2003.11.003

T. Werry, P. Sexton, and A. Christopoulos, ???Ins and outs??? of seven-transmembrane receptor signalling to ERK, Trends in Endocrinology and Metabolism, vol.16, issue.1, pp.26-33, 2005.
DOI : 10.1016/j.tem.2004.11.008

R. Wetzker and F. Böhmer, Opinion: Transactivation joins multiple tracks to the ERK/MAPK cascade, Nature Reviews Molecular Cell Biology, vol.4, issue.8, pp.651-657, 2003.
DOI : 10.1038/nrm1173

V. Bocchini, R. Casalone, P. Collini, G. Rebel, L. Curto et al., Changes in glial fibrillary acidic protein and karyotype during culturing of two cell lines established from human glioblastoma multiforme, Cell and Tissue Research, vol.19, issue.1, pp.73-81, 1991.
DOI : 10.1007/BF00318141

M. Sciaccaluga, B. Fioretti, L. Catacuzzeno, F. Pagani, and C. Bertollini, CXCL12-induced glioblastoma cell migration requires intermediate conductance Ca2+-activated K+ channel activity, AJP: Cell Physiology, vol.299, issue.1, pp.175-184, 2009.
DOI : 10.1152/ajpcell.00344.2009

C. Di, A. Mattox, S. Harward, and C. Adamson, Emerging Therapeutic Targets and Agents for Glioblastoma Migrating Cells, Anti-Cancer Agents in Medicinal Chemistry, vol.10, issue.7, 2010.
DOI : 10.2174/187152010793498618

J. Guillamo, F. Lisovoski, C. Christov, L. Guérinel, C. Defer et al., Migration pathways of human glioblastoma cells xenografted into the immunosuppressed rat brain, Journal of Neuro-Oncology, vol.52, issue.3, pp.205-215, 2001.
DOI : 10.1023/A:1010620420241

H. Wang, D. Guo, F. Ye, G. Xi, and B. Wang, Effect and mechanism of epidermal growth factor on proliferation of GL15 gliomas cell line, Journal of Huazhong University of Science and Technology, vol.299, issue.5, pp.604-606, 2006.
DOI : 10.1007/s11596-006-0533-4

L. Sun, N. Tran, C. Liang, F. Tang, and A. Rice, Design, Synthesis, and Evaluations of Substituted 3-[(3- or 4-Carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as Inhibitors of VEGF, FGF, and PDGF Receptor Tyrosine Kinases, Journal of Medicinal Chemistry, vol.42, issue.25, pp.5120-5130, 1999.
DOI : 10.1021/jm9904295

C. Porcile, A. Bajetto, F. Barbieri, S. Barbero, and R. Bonavia, Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation, Exp Cell Res, vol.308, 2005.

M. Hermanson, K. Funa, J. Koopmann, D. Maintz, and A. Waha, Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas, Cancer Res, vol.56, pp.164-171, 1996.

M. Nakada, D. Kita, L. Teng, I. Pyko, and T. Watanabe, Receptor Tyrosine Kinases: Principles and Functions in Glioma Invasion, Adv Exp Med Biol, vol.986, pp.143-170, 2013.
DOI : 10.1007/978-94-007-4719-7_8

Y. Kim, E. Kim, Q. Wu, O. Guryanova, and M. Hitomi, Plateletderived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity, Genes Dev, vol.26, 2012.

C. Waters, B. Sambi, K. Kong, D. Thompson, and S. Pitson, Sphingosine 1-Phosphate and Platelet-derived Growth Factor (PDGF) Act via PDGF?? Receptor-Sphingosine 1-Phosphate Receptor Complexes in Airway Smooth Muscle Cells, Journal of Biological Chemistry, vol.278, issue.8, pp.6282-6290, 2003.
DOI : 10.1074/jbc.M208560200

N. Pyne, C. Waters, N. Moughal, B. Sambi, and S. Pyne, Receptor tyrosine kinase???GPCR signal complexes, Biochemical Society Transactions, vol.31, issue.6, pp.1220-1225, 2003.
DOI : 10.1042/bst0311220

A. Wiedon, M. Tölle, J. Bastine, M. Schuchardt, and T. Huang, Uridine adenosine tetraphosphate (Up4A) is a strong inductor of smooth muscle cell migration via activation of the P2Y2 receptor and cross-communication to the PDGF receptor, Biochemical and Biophysical Research Communications, vol.417, issue.3, 2012.
DOI : 10.1016/j.bbrc.2011.12.088

M. Acharya, A. Edkins, B. Ozanne, and W. Cushley, SDF-1 and PDGF enhance alphavbeta5-mediated ERK activation and adhesionindependent growth of human pre-B cell lines, Leukemia, vol.23, 2009.